Trial Profile
A Randomized, Double-blind, Multicenter, Phase Ⅲ Study to Evaluate the Efficacy and Safety of HCP1302 in Both Erectile Dysfunction and Hypertension Patients Being Treated With HGP0904
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs HCP 1302 (Primary) ; Amlodipine
- Indications Erectile dysfunction; Hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 30 Oct 2015 New trial record